Ukraine Pharmaceuticals & Healthcare Q1 2020

Ukraine Pharmaceuticals & Healthcare Q1 2020

Key View:

Opportunities for drugmakers in Ukraine will be determined by the success of the government's healthcare reformagenda. Increases in public funds have been allocated towards medicine reimbursement and healthcare services, and the imminentimplementation of the National Health System should boost access to services. However, we note that poor administration willcontinue to hinder positive outcomes, and the short-term impact of reform may be muted.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central & Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Arterium Corporation
Ukraine Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook